Skip to main content
SpringerLink
Log in
Book cover

Paravasation von Zytostatika pp 91–97Cite as

Cisplatin

  • Chapter

  • 19 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Primärliteratur

  1. Lewis KP, Medina WD: Cellulitis and fibrosis due to cis-diamminedichloroplatinum (II) (platinol) infiltration. Cancer Treat Rep 64: 1162–1163, 1980.

    PubMed  CAS  Google Scholar 

  2. Leyden M, Sullivan J: Full-thickness skin necrosis due to inadvertent interstitial infusion of cisplatin. Cancer Treat Rep 67: 199, 1983.

    PubMed  CAS  Google Scholar 

  3. Algarra SM, Dy C, Bilbao I, et al: Cutaneous necrosis after intra-arterial treatment with cisplatin. Cancer Treat Rep 70: 687–688, 1986.

    Google Scholar 

  4. Bairey O, Bishara J, Stahl B, et al: Severe tissue necrosis after cisplatin extravasation at low concentration: possible “immediate recall phenomenon”. J Natl Cancer Inst 89: 1233–1234, 1997.

    Article  PubMed  CAS  Google Scholar 

  5. Howell SB, Taetle R: Effect of sodium thiosulfate on cis-dichlorodiammineplatinum (II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat Rep 64: 611–616, 1980.

    PubMed  CAS  Google Scholar 

  6. Bertelli G, Gozza A, Forno GB, et al: Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 13: 2851–2855, 1995.

    PubMed  CAS  Google Scholar 

  7. Bertelli G, Dini D, Forno G, et al: Dimethylsulphoxide and cooling after extravasation of antitumour agents. Lancet 341: 1098–1099, 1993.

    Google Scholar 

  8. Fields S, Koeller J, Topper RL, et al: Local soft tissue toxicity following cisplatin extravasation. J Natl Cancer Inst 82: 1649–1650, 1990.

    Article  PubMed  CAS  Google Scholar 

  9. Bertelli G: Prevention and management of extravasation of cytotoxic drugs. Drug Safety 12: 245–255, 1995.

    Article  PubMed  CAS  Google Scholar 

  10. Stanley A: Managing complications of chemotherapy. In: Allwood M, Stanley A, Wright P (eds) The Cytotoxics Handbook. Radcliffe Medical Press, 3rd edition: 105–124, 1997.

    Google Scholar 

  11. Root T: Chemotherapeutic agents: Cisplatin. In: Allwood M, Stanley A, Wright P (eds) The Cytotoxics Handbook. Radcliffe Medical Press, 3rd edition: 203–207, 1997.

    Google Scholar 

  12. Ignoffo RJ, Friedman MA: Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treat Rev 7: 17–27, 1980.

    Article  PubMed  CAS  Google Scholar 

  13. Schneider G: Paravasate von Zytostatika. Diagnostik und Therapie. Aina S. Schneider Verlag, 6. Auflage: 1–17, 1999.

    Google Scholar 

  14. Schneider SM, Distelhorst CW: Chemotherapy-induced emergencies. Semin Oncol 16: 572–578, 1989.

    PubMed  CAS  Google Scholar 

  15. Gain M, Melzer S, Meyer-Jürshof A, et al: Allgemeiner Teil: Behandlung von Paravasaten. In: Gain M, et al (Hrsg) ADKA-Zytostatika-Handbuch, Pharmazeutisch-wissenschaftliche Monographien. Verlag Heiner Biller, Band 1, 2. Auflage: A42–44, 1997.

    Google Scholar 

  16. Gain M, Melzer S, Meyer-Jürshof A, et al: Cisplatin: Behandlung von Paravasaten. In: Gain M, et al (Hrsg) ADKA-Zytostatika-Handbuch, Pharmazeutisch-wissenschaftliche Monographien. Verlag Heiner Biller, Band 1, 2. Auflage: 61, 1997.

    Google Scholar 

  17. Dorr RT: Pharmacologic management of vesicant chemotherapy extravasations. In: Dorr RT, Von Hoff DD (eds) Cancer Chemotherapy Handbook. Appleton & Lange, 2nd edition: 109–118, 1994.

    Google Scholar 

  18. Dorr RT: Antidotes to vesicant chemotherapy extravasations. Blood Rev 4: 41–60, 1990.

    Article  PubMed  CAS  Google Scholar 

  19. Cox K, Stuart-Harris R, Abdini G, et al: The management of cytotoxicdrug extravasation: guide-lines drawn up by a working party for the Clinical Oncological Society of Australia. Med J Aust 148: 185–189, 1988.

    PubMed  CAS  Google Scholar 

  20. Mullin S, Beckwith MC, Tyler LS: Prevention and management of antineoplastic extravasation injury. Hosp Pharm 35: 57–76, 2000.

    Google Scholar 

  21. Barth J: Paravasate und deren Behandlung. In: Barth J (Hrsg) ZytostatikaHerstellung in der Apotheke. Deutscher Apotheker Verlag, Kap. VI-3: 1–9, 2000.

    Google Scholar 

  22. Buchanan GR, Buchsbaum HJ, O’Banion K, et al: Extravasation of dactinomycin, vincristine, and cisplatin: studies in an animal model. Med Pediatr Oncol 13: 375–380, 1985.

    Article  PubMed  CAS  Google Scholar 

  23. Dorr RT, Alberts DS, Soble M: Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone. Cancer Chemother Pharmacol 16: 91–94, 1986.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Austrian Breast and Colorectal Cancer Study Group, Wien, Österreich

    Dr. Ines Mader

  2. SMZ Floridsdorf, Krankenhaus und Geriatriezentrum, Wien, Österreich

    Mag. pharm. Patrizia Fürst-Weger

  3. Univ.-Klinik für Innere Medizin I, Klinische Abteilung für Onkologie, Wien, Österreich

    Univ.-Prof. Dr. Robert M. Mader

  4. Anstaltsapotheke, Landeskrankenhaus — Universitätskliniken Innsbruck, Wien, Österreich

    Mag. pharm. Dr. Elisabeth I. Semenitz

  5. Apotheke der Krankenanstalt Rudolfstiftung, Wien, Österreich

    Mag. Dr. Robert Terkola

  6. Apotheke LKH-Univ.-Klinikum Graz, Wien, Österreich

    Mag. Sabine M. Wassertheurer

Authors
  1. Dr. Ines Mader
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mag. pharm. Patrizia Fürst-Weger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Univ.-Prof. Dr. Robert M. Mader
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mag. pharm. Dr. Elisabeth I. Semenitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mag. Dr. Robert Terkola
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mag. Sabine M. Wassertheurer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Wien

About this chapter

Cite this chapter

Mader, I., Fürst-Weger, P., Mader, R.M., Semenitz, E.I., Terkola, R., Wassertheurer, S.M. (2002). Cisplatin. In: Paravasation von Zytostatika. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3799-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-3799-4_13

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-3800-7

  • Online ISBN: 978-3-7091-3799-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation